| Summary: | Background: Recent studies have shown that blood-based miRNAs are dysregulated in patients with acute myocardial infarction (AMI) and are therefore a potential tool for the diagnosis of AMI. Therefore, this study summarized and evaluated studies focused on microRNAs as novel biomarkers for the diagnosis of AMI from the last ten years.Methods: MEDLINE, the Cochrane Central database, and EMBASE were searched between January 2010 and December 2019. Studies that assessed the diagnostic accuracy of circulating microRNAs in AMI were chosen. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, and area under the curve (AUC) were used to assess the test performance of miRNAs.Results: A total of 58 studies that included 8,206 participants assessed the diagnostic accuracy of circulating miRNAs in AMI. The main results of the meta-analyses are as follows: (1) Total miRNAs: the overall pooled sensitivity and specificity were 0.82 (95% CI: 0.79–0.85) and 0.87 (95% CI: 0.84–0.90), respectively. The AUC value was 0.91 (95% CI: 0.88–0.93) in the overall summary receiver operator characteristic (SROC) curve. (2) The panel of two miRNAs: sensitivity: 0.88 (95% CI: 0.77–0.94), specificity: 0.84 (95% CI: 0.72–0.91), AUC: 0.92 (95% CI: 0.90–0.94). (3) The panel of three miRNAs: sensitivity: 0.91 (95% CI: 0.85–0.94), specificity: 0.87 (95% CI: 0.77–0.92), AUC: 0.92 (95% CI: 0.89–0.94). (4) Results by types of miRNAs: miRNA-1: sensitivity: 0.78 (95% CI: 0.71–0.84), specificity: 0.86 (95% CI: 0.77–0.91), AUC: 0.88 (95% CI: 0.85–0.90); miRNA-133a: sensitivity: 0.85 (95% CI: 0.69–0.94), specificity: 0.92 (95% CI: 0.61–0.99), AUC: 0.93 (95% CI: 0.91–0.95); miRNA-208b: sensitivity: 0.80 (95% CI: 0.69–0.88), specificity: 0.96 (95% CI: 0.77–0.99), AUC: 0.91 (95% CI: 0.88–0.93); miRNA-499: sensitivity: 0.85 (95% CI: 0.77–0.91), specificity: 0.95 (95% CI: 0.89–0.98), AUC: 0.96 (95% CI: 0.94–0.97).Conclusion: miRNAs may be used as potential biomarkers for the detection of AMI. For single, stand-alone miRNAs, miRNA-499 may have better diagnostic accuracy compared to other miRNAs. We propose that a panel of multiple miRNAs with high sensitivity and specificity should be tested.
|
|---|
